News
TMPTF
0.350
NaN%
--
TempraMed begins trading on OTCQB Venture Market under TMPTF
PUBT · 1d ago
TempraMed Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
Newsfile · 1d ago
TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million Lives
Newsfile · 07/09 11:00
TempraMed Signs LOI for Exclusive Distribution in Kuwait, Expanding Presence in High-Growth Gulf Region Healthcare Market
Newsfile · 07/06 11:00
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Newsfile · 06/30 07:05
TempraMed Signs Non-Binding LOI with National Distributor in Saudi Arabia
Newsfile · 06/26 20:10
TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally
Newsfile · 06/04 11:00
TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other Medications
Newsfile · 05/22 15:57
TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product
Newsfile · 05/14 07:00
More
Webull provides a variety of real-time TMPTF stock news. You can receive the latest news about TempraMed Tech through multiple platforms. This information may help you make smarter investment decisions.
About TMPTF
TempraMed Technologies Ltd. is a Canada-based company. The Company is engaged in providing temperature-controlled medication storage solutions. It develops patented, FDA-registered, space-grade thermal insulation devices that work 24/7 for years without charging or external power. These devices operate continuously without the need for charging or external power sources. Its product line includes VIVI Cap and VIVI Epi, and the Company is developing a technology platform intended to support the management of temperature-sensitive medications. The Company has operations in North America, Europe, and Asia.